
Valerie Rodriguez-garcia
Examiner (ID: 13670, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1621, 1759, 1626 |
| Total Applications | 1146 |
| Issued Applications | 752 |
| Pending Applications | 83 |
| Abandoned Applications | 331 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9113322
[patent_doc_number] => 08569496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Piperazine salt and a process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 13/140232
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3793
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140232 | Piperazine salt and a process for the preparation thereof | Dec 16, 2009 | Issued |
Array
(
[id] => 7561874
[patent_doc_number] => 20110275707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'SUBSTITUTED AFPO (6-ARYL-4H-FURO[3,2-C]PYRAN-4-ONE) DERIVATIVES AS ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/140330
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9360
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275707.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140330
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140330 | SUBSTITUTED AFPO (6-ARYL-4H-FURO[3,2-C]PYRAN-4-ONE) DERIVATIVES AS ANTI-CANCER AGENTS | Dec 15, 2009 | Abandoned |
Array
(
[id] => 9427894
[patent_doc_number] => 08703971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Thiophene-containing organic photoelectric materials, their preparation methods and solar cell devices'
[patent_app_type] => utility
[patent_app_number] => 13/514947
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4212
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514947 | Thiophene-containing organic photoelectric materials, their preparation methods and solar cell devices | Dec 13, 2009 | Issued |
Array
(
[id] => 7652093
[patent_doc_number] => 20110301362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'NOVEL LIQUID TETRACARBOXYLIC DIANHYDRIDES AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/202067
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6945
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301362.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202067 | Liquid tetracarboxylic dianhydrides and process for the preparation thereof | Dec 7, 2009 | Issued |
Array
(
[id] => 13963
[patent_doc_number] => 07803832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides'
[patent_app_type] => utility
[patent_app_number] => 12/628691
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42307
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803832.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628691 | N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides | Nov 30, 2009 | Issued |
Array
(
[id] => 8160471
[patent_doc_number] => 20120101153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'ROCAGLAOL DERIVATIVES AS CARDIOPROTECTANT AGENTS AND AS ANTINEOPLASTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/130140
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27521
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101153.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130140
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130140 | ROCAGLAOL DERIVATIVES AS CARDIOPROTECTANT AGENTS AND AS ANTINEOPLASTIC AGENTS | Nov 23, 2009 | Abandoned |
Array
(
[id] => 6016938
[patent_doc_number] => 20110224276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => ' OPTICAL ISOMER OF PHENYLPROPIONIC ACID AND ITS MEDICINAL USE'
[patent_app_type] => utility
[patent_app_number] => 13/130603
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14898
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224276.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130603
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130603 | OPTICAL ISOMER OF PHENYLPROPIONIC ACID AND ITS MEDICINAL USE | Nov 19, 2009 | Abandoned |
Array
(
[id] => 7696119
[patent_doc_number] => 20110230471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN'
[patent_app_type] => utility
[patent_app_number] => 13/131696
[patent_app_country] => US
[patent_app_date] => 2009-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19090
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230471.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131696 | BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN | Nov 4, 2009 | Abandoned |
Array
(
[id] => 8340235
[patent_doc_number] => 08242163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Pyrone-indole derivatives and process for their preparation'
[patent_app_type] => utility
[patent_app_number] => 12/612001
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14730
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12612001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/612001 | Pyrone-indole derivatives and process for their preparation | Nov 3, 2009 | Issued |
Array
(
[id] => 7502255
[patent_doc_number] => 20110263854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Improved Process For The Preparation Of Endothelin Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/127568
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8347
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263854.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127568 | Process for the preparation of endothelin receptor antagonists | Nov 3, 2009 | Issued |
Array
(
[id] => 7502254
[patent_doc_number] => 20110263853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'HPLC METHOD FOR THE ANALYSIS OF BOSETAN AND RELATED SUBSTANCES AND USE OF THESE SUBSTANCES AS REFERENCE STANDARDS AND MARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/126332
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4772
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263853.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126332 | HPLC method for the analysis of bosetan and related substances and use of these substances as reference standards and markers | Nov 1, 2009 | Issued |
Array
(
[id] => 8621487
[patent_doc_number] => 08354401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-15
[patent_title] => 'Oxazolidinone amide aromatic compounds for supressing MMP-9 production'
[patent_app_type] => utility
[patent_app_number] => 13/126119
[patent_app_country] => US
[patent_app_date] => 2009-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67943
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126119
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126119 | Oxazolidinone amide aromatic compounds for supressing MMP-9 production | Oct 26, 2009 | Issued |
Array
(
[id] => 8713354
[patent_doc_number] => 08399494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => '2,5-disubstituted phenyl carboxamide orexin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/126620
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18560
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126620
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126620 | 2,5-disubstituted phenyl carboxamide orexin receptor antagonists | Oct 25, 2009 | Issued |
Array
(
[id] => 9441135
[patent_doc_number] => 08710246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Substituted thiophene pentamers'
[patent_app_type] => utility
[patent_app_number] => 13/124621
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13675
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124621
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124621 | Substituted thiophene pentamers | Oct 18, 2009 | Issued |
Array
(
[id] => 7567994
[patent_doc_number] => 20110288057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/123681
[patent_app_country] => US
[patent_app_date] => 2009-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26192
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288057.pdf
[firstpage_image] =>[orig_patent_app_number] => 13123681
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/123681 | SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS | Oct 11, 2009 | Abandoned |
Array
(
[id] => 7530486
[patent_doc_number] => 07842708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/573230
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115735
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573230 | Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors | Oct 4, 2009 | Issued |
Array
(
[id] => 6546927
[patent_doc_number] => 20100016383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => '4-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 12/564995
[patent_app_country] => US
[patent_app_date] => 2009-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24676
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564995 | 4-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES | Sep 22, 2009 | Abandoned |
Array
(
[id] => 6177621
[patent_doc_number] => 20110178060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE OF SAME'
[patent_app_type] => utility
[patent_app_number] => 13/119743
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93010
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178060.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119743 | Nitrogen-containing heterocyclic compound and use of same | Sep 17, 2009 | Issued |
Array
(
[id] => 7650949
[patent_doc_number] => 20110300218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS'
[patent_app_type] => utility
[patent_app_number] => 13/063029
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11711
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 50
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300218.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063029
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063029 | NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS | Sep 7, 2009 | Abandoned |
Array
(
[id] => 5973264
[patent_doc_number] => 20110152361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'NOVEL EPIGALLOCATECHIN GALLATE TETRAMER AND VASCULAR ENDOTHELIAL FUNCTION IMPROVING AGENT CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/060996
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5461
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152361.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060996
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060996 | Epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same | Aug 27, 2009 | Issued |